Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2022-01-24

Clinical Trial Update: Omentin-1 Level in Psoriatic Patients Treated With Narrowband Ultraviolet B Phototherapy Versus Acitretin [Phase 4]

View source ↗

Summary

Phase 4 trial comparing omentin-1 levels in psoriatic patients treated with narrowband UVB phototherapy versus acitretin; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acitretin (Acitretin)
  • narrowband ultraviolet B phototherapy

Snippet

Sponsor: Mahmoud Ahmed Ali Ahmed | Conditions: Psoriasis | Phase 4 | Status: COMPLETED